Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

PRISMA Study (Prospective, Randomized Trial on Intensive Self-Monitoring Blood Glucose Management Added Value in Non-Insulin Treated Type 2 Diabetes Mellitus Patients)

NCT00643474 is registered in ClinicalTrials.gov with Hoffmann-La Roche as lead sponsor.

NCT NCT00643474
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00643474 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
PRISMA Study (Prospective, Randomized Trial on Intensive Self-Monitoring Blood Glucose Management Added Value in Non-Insulin Treated Type 2 Diabetes Mellitus Patients)
Lead sponsor
Hoffmann-La Roche
Phase
Not applicable
Overall status
Completed
Start date
March 31, 2008
Completion date
June 30, 2011
Enrollment
1,000 (actual)
Sites
43

Conditions

As the registry lists them; a condition with its own page is linked.

diabetes mellitus type 2